MAXIMUS, Inc. (NYSE:MMS) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 1,760,000 shares, an increase of 5.4% from the January 15th total of 1,670,000 shares. Based on an average daily volume of 379,700 shares, the short-interest ratio is currently 4.6 days. Approximately 2.8% of the company’s shares are short sold.
In other news, insider Thomas D. Romeo sold 6,758 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $75.71, for a total transaction of $511,648.18. Following the transaction, the insider now directly owns 8,340 shares in the company, valued at approximately $631,421.40. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, Vice Chairman Richard A. Montoni sold 11,028 shares of the stock in a transaction dated Thursday, December 12th. The stock was sold at an average price of $73.33, for a total transaction of $808,683.24. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 30,375 shares of company stock worth $2,250,533. 2.00% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently bought and sold shares of MMS. Resources Management Corp CT ADV acquired a new stake in MAXIMUS during the 3rd quarter worth approximately $65,000. Aigen Investment Management LP acquired a new stake in MAXIMUS during the 4th quarter worth approximately $77,000. Signaturefd LLC increased its position in MAXIMUS by 15.6% during the 3rd quarter. Signaturefd LLC now owns 1,324 shares of the health services provider’s stock worth $102,000 after purchasing an additional 179 shares in the last quarter. Coastal Investment Advisors Inc. acquired a new stake in MAXIMUS during the 3rd quarter worth approximately $103,000. Finally, Larson Financial Group LLC acquired a new stake in MAXIMUS during the 4th quarter worth approximately $109,000. 95.46% of the stock is owned by hedge funds and other institutional investors.
Shares of MMS stock opened at $73.11 on Friday. The firm has a market cap of $4.73 billion, a P/E ratio of 19.07, a PEG ratio of 1.85 and a beta of 0.82. MAXIMUS has a 1-year low of $68.42 and a 1-year high of $82.02. The firm’s 50-day simple moving average is $74.30 and its 200-day simple moving average is $75.50.
MAXIMUS (NYSE:MMS) last announced its quarterly earnings data on Thursday, February 6th. The health services provider reported $0.91 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.91. The business had revenue of $818.23 million for the quarter, compared to analyst estimates of $797.11 million. MAXIMUS had a net margin of 8.01% and a return on equity of 20.54%. The company’s revenue was up 23.1% on a year-over-year basis. During the same period in the prior year, the firm posted $0.86 EPS. As a group, equities analysts expect that MAXIMUS will post 4.01 earnings per share for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be issued a dividend of $0.28 per share. The ex-dividend date is Thursday, February 13th. This represents a $1.12 annualized dividend and a dividend yield of 1.53%. MAXIMUS’s payout ratio is currently 30.11%.
MAXIMUS, Inc provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews.
Read More: Resistance Level
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.